Combination atezolizumab, bevacizumab, pemetrexed and carboplatin for metastatic EGFR mutated NSCLC after TKI failure - Concepedia

Concepedia

Publication | Closed Access

Combination atezolizumab, bevacizumab, pemetrexed and carboplatin for metastatic EGFR mutated NSCLC after TKI failure

69

Citations

42

References

2021

Year

Tai‐Chung Lam, K. C. TSANG, Cheuk‐Wai Choi, Victor Lee, Ka On Lam, Chi‐Leung Chiang, T.H. So, Wing‐Lok Chan, S.F. Nyaw, F. Lim,

MedicineImmunologyCombination AtezolizumabPathologyImmune Checkpoint InhibitorTki FailureMetastatic EgfrCancer TreatmentOncologyRadiation OncologyLung CancerMolecular Oncology

References

	Year	Citations

Page 1

Page 1